Biosciences’ ALD Mary Maxon and Chief Science and Technology Officer Jay Keasling recently attended an event in Washington, D.C., sponsored by the Council on Competitiveness. The briefing on Capitol Hill marked the release of the council’s report, Leverage: Advancing U.S. Bioscience, which captures the outputs of a day-long discussion last year about infrastructure, technology, investment, and talent needed for advancements in U.S. bioscience.